Latest Breaking News On - Tumor associated antigens - Page 1 : comparemela.com

Oncodesign Precision Medicine and Navigo Proteins GmbH Sign a Strategic Collaboration Agreement for the Research and Development of New Systemic Radiotherapy Agents

Oncodesign Precision Medicine and Navigo Proteins GmbH Sign a Strategic Collaboration Agreement for the Research and Development of New Systemic Radiotherapy Agents
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Jan hoflackPhilippe genneKarine lignelHenning afflerbachNavigo affilinsTelix pharmaceuticalsRegulatory newsPrecision medicineNavigo proteins gmbhProteins gmbhOliver buckOncodesign precision medicineChief medical officerTumor associated antigensNavigo proteins

Enterome s OncoMimics™ Immunotherapy EO2401 Significantly Improves Survival Rate in Recurrent Glioblastoma

Positive data from the ROSALIE Phase 1/2 trial presented at 2023 SNO Annual MeetingMedian survival of 14.5 months and 18-months survival rate of 4.

France generalBritish columbiaUnited kingdomAshleyr robinsonPierre belichardGuillaume bayreWeid europeDavid reardonHead of external communicationsHealth scienceSociety for neuroProfessor of medicine at harvard medical schoolOncology at dana farber cancer instituteLifesci advisorsAnnual meetingHarvard medical school

Enterome to Present Updated Data From Phase 1/2 ROSALIE Trial of its Peptide-Based Immunotherapy EO2401 in Recurrent Glioblastoma at SNO 2023

Enterome to Present Updated Data From Phase 1/2 ROSALIE Trial of its Peptide-Based Immunotherapy EO2401 in Recurrent Glioblastoma at SNO 2023
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

France generalBritish columbiaUnited kingdomWeid europeAshleyr robinsonDavid reardonGuillaume bayreJournal of the society for neuroLifesci advisorsSociety for neuroHealth scienceDana farber cancer instituteProfessor of medicine at harvard medical schoolHead of external communicationsPresent updated data from phaseRecurrent glioblastoma

Enterome Presents Immune-Monitoring Data on EO2401 at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

Enterome Presents Immune-Monitoring Data on EO2401 at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesFrance generalLucie aubergeonAshleyr robinsonAlice talpinGuillaume bayreWeid europeLifesci advisorsSociety for immunotherapy of cancerHead of external communicationsHealth sciencePresents immune monitoring dataAnnual meetingTumor associated antigensAna maia

Enterome Selected to The Leukemia & Lymphoma Society s Therapy Acceleration Program

LLS TAP is a strategic funding initiative to accelerate innovative blood cancer therapeutics Strategic equity investment of €3 million to support clinical advancement of EO2463 in Non-Hodgkin's Lymphoma PARIS, Oct.

United statesFrance generalJan fagerbergPierre belichardFast companyLeukemia lymphoma societyHealth scienceInformation resource centerTherapy acceleration programLeukemia lymphoma society therapy acceleration programLymphoma societyHodgkinb cellLore gruenbaumVice presidentAcceleration programChief executive officer